Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bayer: Out of Trouble Come Opportunities

Oct 01 2004

Related Content

Deal Early, Less Often: ZymoGenetics' Broad Deal with Serono

Oct 01 2004

Bioteching UCB-and Maybe Mid-Sized Pharma, Too

Jun 01 2004

Europe's Flavors of Sustainable BioPharma

Sep 01 2004

Biovitrum: A New Flavor of Spin-Off

Oct 01 2002

Related Companies

Bayer AG

Schering-Plough

GSK plc

Pfizer Inc.

ICOS Corporation

Eli Lilly and Company

UCB S.A.

Elan Corporation

Aerovance, Inc.

Roche Holding AG

Novo Nordisk A/S

Affymax, Inc.

ZymoGenetics

Swedish Orphan Biovitrum AB

Merck KGaA

Basilea Pharmaceutica Ltd.

Portola Pharmaceuticals, Inc.

Takeda Pharmaceutical Co. Ltd.

Barrier Therapeutics

Johnson & Johnson

Additional Topics

Strategy BioPharmaceutical

More from Archive

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window